GraMedica Announces a Key Sponsorship in Croatia

GraMedica's Role in Graham International Implant Institute Symposium Addressing Feet Deformities in Opatija, Croatia. End Quote

Detroit, MI (1888PressRelease) June 06, 2015 - GraMedica is excited to be amongst the sponsors of the upcoming symposium, Current Concepts in the Diagnosis and Treatment of Talotarsal Joint Subluxation, held June 17-19, 2015 in Matulji, Opatija, Croatia. Created by The Graham International Implant Institute (GIII), the program consists of a number of expert speakers from more than nine different countries presenting an array of the latest education, research and technology in foot and ankle care.

Studies in Foot & Ankle International highlight a significant increase in foot and ankle specialists. Feet provide the base of the musculoskeletal system. If damaged it can cause problems throughout a person's body. Clinicians seek to understand how to diagnose and treat these issues. To meet the growing demand for training in the foot and ankle specialty, GIII is committed to continuing education programs for foot specialists to learn the the best care available to their patients.

Patients with a Talotarsal joint dislocation can suffer from a variety of symptoms including unstable feet, feet tiring easily, bunions, damage or inflammation of tendons, and moderate to severe pain in the feet, shins, knees, hips, and/or back. In one incident reported in a BMJ Case Report by Bajuri MY, et al., a neglected foot subtalar joint dislocation was associated with a neck fracture amongst other serious issues.

The Current Concepts in the Diagnosis and Treatment of Talotarsal Joint Subluxation symposium will be held at three venues in Matulji, Opatija, Croatia. The new Hotel Navis, Villa Kapetanović and Special Orthopaedic Hospital "Dr. Nemec" will hold lectures, hands-on workshops, and live patient settings for specialists in attendance to increase their knowledge and skills in foot and ankle care.

The Graham International Implant Institute, founded in August of 2006, is an organization dedicated in educating foot and ankle specialists to use cutting-edge, ground breaking technologies and procedures. The Graham International Implant Institute has provided world-class training, certification, and support for hundreds of physicians throughout the world.

GraMedica is a global orthopedic medical device company and leader in the development of life-changing foot and ankle products in over 40 countries. Amongst this Macomb, Michigan developer and manufacturer is its HyProCure product, a surgical stent that has been used in thousands of procedures worldwide to treat congenital/acquired talotarsal joint dislocation, a surgically correctable condition that results in the misalignment of the foot and other major structures of the body.

###

space

Other Related Press Releases